Channel Wealth’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,431
Closed -$202K 199
2023
Q2
$202K Sell
2,431
-1,014
-29% -$84.8K 0.12% 174
2023
Q1
$263K Buy
+3,445
New +$286K 0.17% 146

Other funds holding XBI

Channel Wealth's XBI Position: Q3 2023 in Review

Channel Wealth sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2023, closing a stake of 2,431 shares — an estimated $202K sold.

Channel Wealth first reported a position in XBI in Q1 2023 and held it in 2 quarters. The position peaked at $263K in Q1 2023. 679 funds tracked by Wall St. Rank hold XBI as of Q3 2023.

  • Channel Wealth reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2023 after selling out during the quarter.
  • Channel Wealth sold 2,431 State Street SPDR S&P Biotech ETF shares in Q3 2023, an estimated $202K.
  • Channel Wealth first reported a position in State Street SPDR S&P Biotech ETF in Q1 2023 and held it in 2 quarters.
  • Channel Wealth's State Street SPDR S&P Biotech ETF position peaked at $263K in Q1 2023.
  • 679 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2023.

Based on Channel Wealth's 13F filing for Q3 2023, filed 24 Oct 2023.